Venlafaxine

The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition >

< Previous

Venlafaxine

Content

text A A A

Sections

Background | Clinical use | Risks, side effects, and their management | Overdose | Drug interactions

Excerpt

Venlafaxine is a dual reuptake inhibitor for both serotonin and norepinephrine; serotonin reuptake inhibition is prominent at lower doses, whereas norepinephrine reuptake inhibition becomes more significant at higher doses.

Your session has timed out. Please sign back in to continue.

Username

Password

Sign in via Athens (What is this?)

Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.

Forgot Password?

Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).

Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.

All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.

Venlafaxine

Sections

Excerpt

SECTION QUICK LINKS